Seed/Nut/Grain Variants · Seed Oils
Amla Seed Oil (Phyllanthus emblica) (Phyllanthus emblica)
Preliminary EvidenceCompound
Hermetica Superfood Encyclopedia
Amla seed oil is cold-pressed from the seeds of Phyllanthus emblica and contains tocopherols, phytosterols, and linolenic acid as its primary bioactive compounds. These constituents exhibit antioxidant activity primarily through free radical scavenging and lipid peroxidation inhibition, though most robust research on Phyllanthus emblica focuses on the fruit pulp rather than the seed oil fraction.
Amla Seed Oil is derived from the seeds of Phyllanthus emblica (Indian gooseberry), a tree native to India used in traditional medicine for over 3,000 years. The oil is typically extracted via cold-pressing from seeds, yielding a liquid fixed oil rich in fatty acids and phytosterols, distinct from the vitamin C-rich fruit extracts.
No human clinical trials, RCTs, or meta-analyses were found specifically for Amla Seed Oil. While general Amla fruit extract studies exist (such as PMID 22387329 for diabetes management), these do not apply to the seed oil, which has a different chemical profile lacking the vitamin C and tannins found in fruit extracts.
No clinically studied dosage ranges are documented for Amla Seed Oil in any form. Fruit-based Amla studies use 500-1000 mg/day of extracts standardized to 20-50% tannins, but seed oil lacks such standardization or dosing data. Consult a healthcare provider before starting any new supplement.
Amla Seed Oil (Phyllanthus emblica) is a fixed oil extracted from the seeds of the Indian gooseberry. Fatty acid composition is the primary nutritional consideration: linoleic acid (omega-6) is the dominant fatty acid at approximately 40-50% of total fatty acids, followed by oleic acid (omega-9) at approximately 25-35%, palmitic acid (saturated) at approximately 10-15%, stearic acid (saturated) at approximately 5-8%, and linolenic acid (omega-3) at approximately 2-5%. Minor fatty acids include palmitoleic acid (<1%) and arachidic acid (<1%). Tocopherol content (vitamin E fraction) is present at estimated 200-400 mg/kg total tocopherols, with gamma-tocopherol as the likely predominant form based on seed oil profiles of related species, though Phyllanthus emblica seed oil-specific tocopherol fractionation data is limited in peer-reviewed literature. Phytosterols including beta-sitosterol and stigmasterol are present in the unsaponifiable fraction at estimated 0.3-0.6% of total oil weight. The oil contains trace phospholipids from the seed matrix. Unlike the fruit pulp, the seed oil contains negligible vitamin C (ascorbic acid), as ascorbic acid is water-soluble and does not partition into the lipid fraction during cold-press or solvent extraction. Bioavailability: fatty acids are delivered in triglyceride form with standard lipid digestion and absorption kinetics; tocopherols and phytosterols in oil matrices have moderate-to-good bioavailability compared to dry supplement forms. Emblicanin A and B (the signature tannin-based antioxidants of Amla fruit) are not present in the seed oil fraction, as these polyphenols are hydrophilic and concentrate in the fruit pulp, not the seed lipid. Protein and fiber content are negligible (<0.1%) in the refined or cold-pressed oil. No reliable seed oil-specific mineral content data is available in published literature; mineral contribution from this oil is considered nutritionally insignificant.
The tocopherols (primarily alpha- and gamma-tocopherol) in amla seed oil donate hydrogen atoms to neutralize lipid peroxyl radicals, interrupting chain oxidation reactions in cell membranes. Phytosterols such as beta-sitosterol compete with cholesterol for intestinal absorption via NPC1L1 transporter inhibition, while also modulating NF-κB signaling pathways to reduce pro-inflammatory cytokine expression. Linolenic acid (an omega-3 fatty acid present in the oil) serves as a precursor to anti-inflammatory eicosanoids, potentially influencing COX and LOX enzyme activity, though these mechanisms are extrapolated from general fatty acid research rather than amla seed oil-specific trials.
No peer-reviewed clinical trials have been conducted specifically on Phyllanthus emblica seed oil in human subjects, making evidence-based claims about its isolated effects premature. The majority of clinical research on Phyllanthus emblica involves standardized fruit extracts (such as Amlamax or Emblica officinalis fruit powder), with studies in 30–100 participants showing reductions in LDL oxidation and fasting glucose; these findings cannot be directly extrapolated to the seed oil. In vitro studies confirm antioxidant activity via DPPH radical scavenging assays, with IC50 values comparable to other plant seed oils, but cell-culture data does not establish clinical efficacy. Manufacturer claims regarding blood sugar, immune, and detoxification support for the seed oil specifically lack published randomized controlled trial validation as of current literature.
Amla seed oil applied topically is generally considered well-tolerated, with no significant adverse events reported in cosmetic use studies, though individuals with tree nut or plant oil sensitivities should patch-test before broad application. When consumed orally, the high polyunsaturated fatty acid content may theoretically potentiate the effects of anticoagulant medications such as warfarin by enhancing platelet aggregation inhibition, warranting caution in patients on blood thinners. Phyllanthus emblica fruit preparations have shown mild hypoglycemic effects in some studies, suggesting that concentrated seed oil consumed orally could theoretically interact with antidiabetic medications like metformin or insulin, though direct evidence for the oil is absent. Pregnant and breastfeeding individuals should avoid oral supplementation with amla seed oil due to the complete absence of safety data in these populations.
